Trials / Sponsors / SystImmune Inc.
SystImmune Inc.
Industry · 6 registered clinical trials — 5 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors Gastric Adenocarcinoma, Advanced Pancreatic Ductal Adenocarcinoma, Esophageal Adenocarcinoma | Phase 1 | 2025-07-30 |
| Recruiting | Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Small Cell Lung Cancer Metastatic or Locally Advanced, Neuroendocrine Cancer, Metastatic or Locally Advanced Neuroendocrine Prostate Cancer | Phase 1 | 2025-04-28 |
| Active Not Recruiting | Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors Breast Cancer Stage III, HER2-positive Metastatic Breast Cancer, Unresectable Breast Carcinoma | Phase 1 | 2025-04-10 |
| Recruiting | Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1 Relapsed/Refractory Acute Myeloid Leukemia | Phase 1 | 2024-12-19 |
| Recruiting | Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors Endometrial Cancer, Cervical Cancer, Ovarian Cancer | Phase 1 | 2024-02-09 |
| Recruiting | Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Sol Non Small Cell Lung Cancer, Lung Cancer, Breast Cancer | Phase 1 | 2023-08-08 |